(Date:8/27/2008)... The American Society for Therapeutic Radiology an...ist Audrey Evans, M.D., as its 2008 honorary membe...Ceremony held Tuesday, September 23, at 10:00 a.m....r. Evans has been on the forefront of the treatmen...as one of the co-founders of the original Ronald M...
(Date:8/27/2008)...inding could lead to new drugs in fight against ob... (HealthDay News) -- A chemical produced in the br... likelihood of becoming obese, according to a new ...a group of 33 people who had WAGR syndrome, a gene...illion people. WAGR is an acronym for the symptoms...
(Date:8/27/2008)...dding Velcade to standard drug therapy prolonged s... 27 (HealthDay News) -- Patients with multiple mye... lived longer and better by adding the drug Velcad...he finding could make multiple myeloma, a cancer o...a lethal disease. And it would be particularly val...
(Date:8/27/2008)...tudy also uncovers risks associated with treating ...DAY, Aug. 27 (HealthDay News) -- Scientists from t...st gene directly associated with the onset of seve... age-related macular degeneration that currently t...ericans. , The discovery, based on work with bo...
Breaking Medicine News(10 mins):Health News:ASTRO selects pediatric oncologist as 2008 honorary member 2Health News:Low Levels of Brain Chemical May Control Appetite 2Health News:Combination Therapy Helps to Combat Myeloma 2Health News:Combination Therapy Helps to Combat Myeloma 3Health News:Gene Linked to 'Dry' Macular Degeneration 2Health News:Gene Linked to 'Dry' Macular Degeneration 3...nce 2001, the government and the media have period...reats of bioterrorism. // Now, a team of researche...eshiva University has found that such messages mea...s, which could pose adverse health effects. In t...
...o studies have found that the Schering-Plough fung...oval recently is better than older drugs in protec...ing to two studies financed by the company. The r...n the New England Journal of Medicine. Apart fro...
... a landmark in the series of release of Software T...e contemplated, //the Department of Information Te...g software tools and fonts in as many as seven Ind... the public. Shri.Maran, Minister of Communicatio...
...e new Director-General of the World Health Organiz...dealing with all pandemics currently threatening m...oint out that with enough effort and political wil...O reports released last week depict that deaths fr...
Other Medicine News:Health News:Potential Threats of Bioterrorism 2Health News:Potential Threats of Bioterrorism 3Health News:Software Tools & Fonts in Seven Indian Languages 2(Date:8/26/2008)...Mass., Aug. 26 /- Cambridge Research ...e of the Maestro(TM) EX In,Vivo Imaging System. Th...LEX technology and becomes the entry-level instrum...(Photo: http://www.newscom.com/cgi-bin/prnh/20080...ificant advancement of CRi,s unique,solid-state tu...
(Date:8/25/2008)...vers Stem Cells Found in Menstrual Blood May Offer...r Time-Pressed Women, OLDSMAR, Fla., Aug. 25 /PRN...most women would agree that there never seems to b...an spends on doing something just,for herself usua... others.,This reality has led many women in need o...
(Date:8/25/2008)...O, Calif., Aug. 25 /- Anthera Pharmac...company developing,anti-inflammatory drugs, today ...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib when...ute,Coronary Syndrome (ACS) event., The FRANCIS t...
(Date:8/22/2008)...E, Md., Aug. 22 /- Human Ge...ed that it has completed the,enrollment and initia... of,HGS-ETR1 (mapatumumab) in combination with the... first-line therapy in advanced non-small cell,lun.../cgi-bin/prnh/20080416/HGSLOGO ), "There is an u...
Breaking Medicine Technology:CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation 10888 1Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation 10888 2Core blimey 21 University of Leicester scientist calls for geological time machine 2107 1New York Methodist Hospital to study airway bypass treatment for emphysema 10880 1New York Methodist Hospital to study airway bypass treatment for emphysema 10880 2MedStar Health Unveils Rx for Success Program at Vivien T Thomas Medical Arts Academy 10875 1MedStar Health Unveils Rx for Success Program at Vivien T Thomas Medical Arts Academy 10875 2MedStar Health Unveils Rx for Success Program at Vivien T Thomas Medical Arts Academy 10875 3MedStar Health Unveils Rx for Success Program at Vivien T Thomas Medical Arts Academy 10875 4...g Pharmacokinetics and Dose Proportionality of,Com...harmaceutics,Journal -, LAVAL, QC, June 29, 2007 /...nced that it will present a poster discussing the ...amadol at the 3rd,International Forum on Pain Medi...l, Canada. , The poster compares two different tit...
... 2 July,2007: Chi-Med, the Hutchison Whampoa backe...nces positive results for its Phase II,proof-of-co...ative,Colitis, a form of inflammatory bowel diseas...as well tolerated and showed an,equivalent drop in...salazine, the current first-line standard of care ...
Other Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8Opmi Vario/S88 system surgical microscope. It is applicable for neurosurgery, spinal, ENT and P&R surgery.
Micro Dissecting Curette, 5 1/2", Round.
Toothed pituitary rongeur.
Micro pituitary style scissors, alligator action, semi-malleable shaft. Curved right.
Medicine Products: